How to manage an adnexal cyst?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Adnexal Cysts

Transvaginal ultrasound is the first-line imaging modality for characterizing adnexal cysts, with management decisions based on cyst characteristics, size, and menopausal status. 1

Initial Evaluation

  • Transvaginal ultrasound combined with transabdominal ultrasound is the most useful initial approach for evaluating suspected adnexal masses 1
  • Color or power Doppler should be included in the ultrasound examination to evaluate vascularity of any solid component 1
  • Most adnexal masses can be categorized as cystic, solid, or mixed based on sonographic appearance 1

Management Based on Cyst Type

Simple Cysts

  • Simple cysts establish a benign process in 98.7% of premenopausal women 1
  • For postmenopausal women, follow-up is recommended only for simple cysts >3 cm (or >5 cm if exceptionally well visualized) 1
  • For premenopausal women, simple cysts ≤3 cm require no follow-up 1

Hemorrhagic Cysts

  • Premenopausal hemorrhagic cysts ≤5 cm require no further management 1
  • Premenopausal hemorrhagic cysts >5 cm but <10 cm require follow-up in 8-12 weeks 1
  • Hemorrhagic cysts in postmenopausal women warrant further evaluation by ultrasound specialist, gynecologist referral, or MRI 1

Dermoid Cysts and Endometriomas

  • For premenopausal patients with dermoid cysts or endometriomas <10 cm, optional initial follow-up at 8-12 weeks with annual surveillance if not surgically removed 1
  • In postmenopausal patients, annual ultrasound follow-up may be considered, but the risk of malignant transformation is higher for endometriomas 1
  • If morphology changes or vascular components develop, referral to ultrasound specialist or MRI is recommended 1

Nonsimple Unilocular Smooth Cysts

  • Premenopausal cysts ≤3 cm require no management 1
  • Premenopausal cysts >3 cm and <10 cm need follow-up ultrasound in 8-12 weeks 1
  • If cyst persists or enlarges, referral to ultrasound specialist or MRI should be considered 1
  • For postmenopausal women, additional characterization via specialist ultrasound or MRI should be considered regardless of size 1

Risk Stratification and Referral

O-RADS Classification System

  • O-RADS 3 lesions (1% to <10% risk of malignancy): Management by general gynecologist with possible ultrasound specialist consultation or MRI 1
  • O-RADS 4 lesions (10% to <50% risk of malignancy): Consultation with gynecologic oncology prior to removal or referral for management 1
  • O-RADS 5 lesions (50%-100% risk of malignancy): Direct referral to gynecologic oncologist 1

Indeterminate Masses

  • Up to 22-24% of adnexal masses remain indeterminate after initial ultrasound 1
  • MRI is the most useful modality for further evaluation of indeterminate lesions 1
  • CT is not recommended for characterization of indeterminate adnexal masses 1

Special Considerations

  • Initial management by a gynecologic oncologist is the second most important prognostic factor (after stage) for long-term survival in patients with ovarian malignancy 1
  • Surgical exploration of benign lesions has reported complication rates of 2-15%, emphasizing the importance of accurate preoperative characterization 1
  • For cysts that decrease in size by at least 10-15% at any time, further follow-up is unnecessary 2

Pitfalls to Avoid

  • Misinterpreting endosalpingeal folds in hydrosalpinx as solid components 1
  • Mistaking pedunculated leiomyomas for solid ovarian masses - careful identification of normal ovaries and blood supply from uterine vessels helps avoid this error 1
  • Relying on CT for characterization of adnexal masses when MRI is better established for this purpose 1
  • Assuming all cysts in postmenopausal women are malignant - recent evidence shows simple cysts have very low malignancy risk regardless of menopausal status 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.